Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2712
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSelvadurai, Yoshua-
dc.contributor.authorLe Fevre, Emily R-
dc.contributor.authorMervis, Jonathan-
dc.contributor.authorFitzgerald, Dominic A-
dc.date.accessioned2024-09-05T00:57:21Z-
dc.date.available2024-09-05T00:57:21Z-
dc.date.issued2024-08-02-
dc.identifier.citationS1526-0542(24)00057-5.en
dc.identifier.urihttps://hdl.handle.net/1/2712-
dc.description.abstractHereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant condition characterised by small telangiectasias and larger multisystem arteriovenous malformations (AVMs). Common sites of AVMs include in the nose, lungs, brain and liver. These lesions are prone to rupture, leading to complications including recurrent epistaxis and significant haemorrhage. Pulmonary hypertension (PH) can also occur. This review presents an update on the genetics, clinical manifestations, management options, and screening recommendations for children with HHT.en
dc.description.sponsorshipPaediatricsen
dc.subjectPaediatricsen
dc.subjectPediatricsen
dc.titleHereditary haemorrhagic telangiectasia: A primer for the paediatricianen
dc.typeJournal Articleen
dc.identifier.doi10.1016/j.prrv.2024.07.003en
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/39214822en
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesGosford Hospitalen
dc.identifier.journaltitlePaediatric Respiratory Reviewsen
dc.type.contentTexten
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
Appears in Collections:Health Service Research
Show simple item record

Page view(s)

24
checked on Nov 29, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.